02616 基石药业－Ｂ
按盘价 
0.910 +0.010 (+1.111%) | 2023/12 - 末期 人民币() | 2022/12 人民币() | 2021/12 人民币() | 2020/12 人民币() | 2019/12 人民币() | |
| 经营活动之现金流量 | -- | (612,469,000) | (1,484,024,000) | (508,070,000) | (1,080,722,000) |
| 投资活动之现金流量 | -- | 365,119,000 | (826,552,000) | 1,180,732,000 | (658,884,000) |
| 融资活动之现金流量 | -- | 28,467,000 | 92,304,000 | 1,389,429,000 | 2,091,332,000 |
| 现金及等同现金之增加/(减少) | -- | (218,883,000) | (2,218,272,000) | 2,062,091,000 | 351,726,000 |
| 期初之现金及现金等价物 | -- | 742,724,000 | 3,024,548,000 | 1,126,436,000 | 701,336,000 |
| 汇率变动之影响 | -- | 34,843,000 | (63,552,000) | (163,979,000) | 73,374,000 |
| 其他 | -- | 0 | 0 | 0 | 0 |
| 期末之现金及现金等价物 | -- | 558,684,000 | 742,724,000 | 3,024,548,000 | 1,126,436,000 |
| 备注： | 实时报价更新时间为29/04/2024 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -367,234,000 |
| 增长率 | -59.317% |
| 每股盈利/(亏损) | RMB -0.290 |
| 每股账面资产净值 (¥) | RMB 0.356 |